Table 1.

Anthropometric and clinical characteristics of patients and controls.

	Patients (32 m/21 f)	Controls (28 m/32 f)	P
Age [year]	12.36 ± 3.15*	13.67 ± 2.80*	0.024
height [SDS]	−0.05 ± 0.87**	0.50 ± 1.06**	0.004
weight [SDS]	0.23 ± 0.78	0.28 ± 0.91	0.747
BMI [SDS]	0.35 ± 0.69*	0.06 ± 0.82*	0.051
BPsys [SDS]	1.76 ± 1.17**	1.07 ± 1.24**	0.003
BPdias [SDS]	1.11 ± 1.21**	0.12 ± 1.30**	<0.001
Duration of Disease [year]	4.75 (0.17–15.25)
Glucose [mmol/l]	9.78 ± 4.67
HbA1c [%]
at time of examination	8.60 ± 1.58
mean during last year	8.59 ± 1.47
Cholesterol [mmol/l]	4.39 ± 0.98
LDL-Cholesterol [mmol/l]	2.40 ± 0.84
HDL-Cholesterol [mmol/l]	1.63 ± 0.34
Triglyceride [mmol/l]	1.16 ± 1.01
normalized Insulindosage [IE/kg/d]	0.37 (0.19–1.05)

Superscripts denote significant differences between patients and controls (*p < 0.05; **p < 0.01).